SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Aug-24 4:34 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 12-Aug-24 | Acquisition (other) | 10,446 | -- | -- | 4% 249.87K to 260.32K | |
14-Aug-24 4:34 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 12-Aug-24 | Acquisition (other) | 27,116 | -- | -- | 10% 260.32K to 287.44K | |
14-Aug-24 4:34 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 12-Aug-24 | Disposition (other) | 74,892 | -- | -- | (26%) 287.44K to 212.54K | |
14-Aug-24 4:34 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 12-Aug-24 | Sale | 35,000 | $26.08 | $912,961.00 | (16%) 212.54K to 177.54K | |
25-Jun-24 6:25 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 24-Jun-24 | Option Exercise | 3,350 | -- | -- | 2% 136.63K to 139.98K | |
10-Jun-24 4:17 PM View: | Rxsight, Inc. (RXST) | 06-Jun-24 | Grant | 2,554 | -- | -- | 6% 45.8K to 48.35K | |
09-May-24 4:30 PM View: | Lensar, Inc. (LNSR) | 07-May-24 | Grant | 22,000 | -- | -- | 4% 521.27K to 543.27K | |
02-Feb-24 4:49 PM View: | Rxsight, Inc. (RXST) | 01-Feb-24 | Gift | 3,000 | -- | -- | (4%) 77.05K to 74.05K | |
02-Feb-24 4:49 PM View: | Rxsight, Inc. (RXST) | 01-Feb-24 | Sale | 28,250 | $49.67 | $1,403,120.00 | (38%) 74.05K to 45.8K | |
18-Aug-23 6:46 PM View: | Rxsight, Inc. (RXST) | 17-Aug-23 | Acquisition (other) | 2,610 | -- | -- | < 1% 747.31K to 749.92K | |
18-Aug-23 6:46 PM View: | Rxsight, Inc. (RXST) | 17-Aug-23 | Acquisition (other) | 21,248 | -- | -- | 3% 749.92K to 771.17K | |
18-Aug-23 6:46 PM View: | Rxsight, Inc. (RXST) | 17-Aug-23 | Disposition (other) | 694,124 | -- | -- | (90%) 771.17K to 77.05K | |
21-Jun-23 6:08 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 16-Jun-23 | Option Exercise | 2,000 | -- | -- | 1% 134.63K to 136.63K | |
05-Jun-23 4:32 PM View: | Rxsight, Inc. (RXST) | 01-Jun-23 | Grant | 5,731 | -- | -- | < 1% 741.58K to 747.31K | |
30-May-23 5:00 PM View: | Lensar, Inc. (LNSR) | 25-May-23 | Grant | 9,288 | -- | -- | 2% 511.98K to 521.27K | |
15-May-23 5:57 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 11-May-23 | Acquisition (other) | 41,219 | -- | -- | 10% 418.88K to 460.1K | |
15-May-23 5:57 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 11-May-23 | Disposition (other) | 215,576 | -- | -- | (47%) 460.1K to 244.52K | |
12-May-23 3:15 PM View: | Rxsight, Inc. (RXST) | 11-May-23 | Acquisition (other) | 98,715 | -- | -- | 11% 901.26K to 999.97K | |
12-May-23 3:15 PM View: | Rxsight, Inc. (RXST) | 11-May-23 | Disposition (other) | 258,390 | -- | -- | (26%) 999.97K to 741.58K | |
17-Mar-23 6:39 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Mar-23 | Acquisition (other) | 52,194 | -- | -- | 9% 582.26K to 634.46K | |
17-Mar-23 6:39 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Mar-23 | Disposition (other) | 215,575 | -- | -- | (34%) 634.46K to 418.88K | |
14-Nov-22 4:34 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 10-Nov-22 | Acquisition (other) | 8,382 | -- | -- | 1% 789.46K to 797.84K | |
14-Nov-22 4:34 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 10-Nov-22 | Disposition (other) | 215,575 | -- | -- | (27%) 797.84K to 582.26K | |
14-Nov-22 4:05 PM View: | Rxsight, Inc. (RXST) | 09-Nov-22 | Acquisition (other) | 107,236 | -- | -- | 10% 1.11M to 1.22M | |
14-Nov-22 4:05 PM View: | Rxsight, Inc. (RXST) | 09-Nov-22 | Disposition (other) | 316,694 | -- | -- | (26%) 1.22M to 901.26K | |
17-Aug-22 4:22 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Aug-22 | Acquisition (other) | 3,749 | -- | -- | < 1% 1.0M to 1.01M | |
17-Aug-22 4:22 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 15-Aug-22 | Disposition (other) | 215,575 | -- | -- | (21%) 1.01M to 789.46K | |
11-Aug-22 4:47 PM View: | Rxsight, Inc. (RXST) | 10-Aug-22 | Acquisition (other) | 107,236 | -- | -- | 8% 1.32M to 1.43M | |
11-Aug-22 4:47 PM View: | Rxsight, Inc. (RXST) | 10-Aug-22 | Disposition (other) | 316,694 | -- | -- | (22%) 1.43M to 1.11M | |
09-Jun-22 6:22 PM View: | Rxsight, Inc. (RXST) | 08-Jun-22 | Acquisition (other) | 126,979 | -- | -- | 8% 1.57M to 1.7M | |
09-Jun-22 6:22 PM View: | Rxsight, Inc. (RXST) | 08-Jun-22 | Disposition (other) | 375,000 | -- | -- | (22%) 1.7M to 1.32M | |
03-Jun-22 8:21 PM View: | Rxsight, Inc. (RXST) | 02-Jun-22 | Grant | 10,349 | -- | -- | < 1% 1.56M to 1.57M | |
31-May-22 11:44 AM View: | Lensar, Inc. (LNSR) | 25-May-22 | Grant | 4,285 | -- | -- | < 1% 507.69K to 511.98K | |
19-May-22 4:06 PM View: | Rxsight, Inc. (RXST) | 17-May-22 | Disposition (other) | 375,000 | -- | -- | (23%) 1.64M to 1.27M | |
17-Mar-22 9:13 PM View: | Rxsight, Inc. (RXST) | 15-Mar-22 | Disposition (other) | 375,000 | -- | -- | (19%) 2.02M to 1.64M | |
07-Jan-22 6:08 PM View: | Oyster Point Pharma, Inc. (OYST) | 05-Jan-22 | Acquisition (other) | 6,839 | -- | -- | 1% 483.8K to 490.63K | |
23-Dec-21 5:34 PM View: | Oyster Point Pharma, Inc. (OYST) | 21-Dec-21 | Acquisition (other) | 6,838 | -- | -- | 1% 678.43K to 685.27K | |
16-Nov-21 7:58 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 11-Nov-21 | Acquisition (other) | 4,348 | -- | -- | < 1% 1.25M to 1.25M | |
16-Nov-21 7:58 PM View: | Tarsus Pharmaceuticals, Inc. (TARS) | 11-Nov-21 | Disposition (other) | 250,000 | -- | -- | (20%) 1.25M to 1.0M | |
20-Oct-21 4:32 PM View: | Oyster Point Pharma, Inc. (OYST) | 18-Oct-21 | Market Sale (Planned) Duplicate | 550,000 | $14.84 | $8,160,740.00 | (38%) 1.43M to 879.9K | 16% |
05-Aug-21 7:34 PM View: | Rxsight, Inc. (RXST) | 03-Aug-21 | Conversion Duplicate | 2,016,780 | -- | -- | 34422% 5.86K to 2.02M | |
05-Aug-21 7:34 PM View: | Rxsight, Inc. (RXST) | 03-Aug-21 | Market Purchase | 31,250 | $16.00 | $500,000.00 | 2% 2.02M to 2.05M | |
02-Aug-21 8:15 PM View: | Rxsight, Inc. (RXST) | 30-Jul-21 | Grant | 5,859 | -- | -- | 100% 0 to 5.86K | |
09-Jun-21 8:44 PM View: | Oyster Point Pharma, Inc. (OYST) | 07-Jun-21 | Grant | 3,466 | -- | -- | < 1% 1.43M to 1.43M | |
07-Jun-21 7:05 PM View: | Glaukos Corp (GKOS) | 03-Jun-21 | Grant | 2,382 | -- | -- | 4% 55.92K to 58.3K | |
14-May-21 4:42 PM View: | Oyster Point Pharma, Inc. (OYST) | 12-May-21 | Acquisition (other) | 10,944 | -- | -- | < 1% 1.42M to 1.43M | |
30-Mar-21 9:45 PM View: | Oyster Point Pharma, Inc. (OYST) | 26-Mar-21 | Acquisition (other) | 10,933 | -- | -- | < 1% 1.73M to 1.74M | |
14-Dec-20 8:45 PM View: | Oyster Point Pharma, Inc. (OYST) | 10-Dec-20 | Acquisition (other) | 27,942 | -- | -- | < 1% 2.98M to 3.0M | |
14-Dec-20 8:45 PM View: | Oyster Point Pharma, Inc. (OYST) | 10-Dec-20 | Disposition (other) | 955,392 | -- | -- | (32%) 3.0M to 2.05M | |
10-Dec-20 8:53 PM View: | Lensar, Inc. (LNSR) | 07-Dec-20 | Grant | 80,157 | -- | -- | 19% 427.54K to 507.69K |